Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 1.95
- Piotroski Score 6.00
- Grade Overweight
- Symbol (GEHC)
- Company GE HealthCare Technologies Inc.
- Price $82.05
- Changes Percentage (-3.36%)
- Change -$2.85
- Day Low $81.84
- Day High $85.26
- Year High $94.55
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products. The Ultrasound segment provides screening, diagnosis, treatment, and monitoring of certain diseases through radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment involved in the provision of medical devices, consumable products, services, and digital solutions through patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal infant care products. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals, administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents, or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes that are injected into a patient prior to a diagnostic imaging scan. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
- Last Earnings 09/18/2024
- Ex-Dividend for 5/16 Dividend 10/18/2024
- Dividend Payable 11/15/2024
- Today N/A
- Next Earnings (Estimated) 02/03/2025
- Fiscal Year End N/A
- Average Stock Price Target $97.00
- High Stock Price Target $110.00
- Low Stock Price Target $74.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $3.44
- Trailing P/E Ratio 22.19
- Forward P/E Ratio 22.19
- P/E Growth 22.19
- Net Income $1.57 B
Income Statement
Quarterly
Annual
Latest News of GEHC
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Here's Why GE HealthCare Technologies (GEHC) is a Strong Value Stock
Utilizing Zacks Style Scores can aid investors in selecting stocks based on value, growth, and momentum. GE HealthCare Technologies Inc., a top medical technology provider, holds a Zacks Rank #3 with ...
By Yahoo! Finance | 2 weeks ago -
GE HealthCare Technologies Inc. (GEHC) Unveils AI Application for Oncology and Launches AI Innovation Lab to Drive Healthcare Advancements
AI's influence extends beyond investing, with companies like Penguin Random House and The New York Times facing copyright issues related to AI use. Anthropic prioritizes AI safety, contrasting with Op...
By Yahoo! Finance | 4 weeks ago -
Jim Cramer on GE HealthCare Technologies (NASDAQ:GEHC) Stock: Will Bounce Back
Jim Cramer's latest portfolio update features GE HealthCare Technologies Inc as the 10th top stock, despite its recent underperformance. Cramer is optimistic about the rebound of tech stocks and the p...
By Yahoo! Finance | 1 month ago
